FDA Warning Letters Released The Weeks Of April 8 And April 15
This article was originally published in The Gray Sheet
Executive Summary
FDA issues warning letters to device manufacturers in Canada, Italy, Japan and the U.S., including Baxter Healthcare Corp.
You may also be interested in...
Resolving Botanicals Deadlock 'Not A Priority' For European Commission
Tensions between industry and the European Commission on the issue of health claims for botanical food supplements were aired on the second day of the BAH's High Level Conference on the Future of Medicines, with the EC saying the EU Green Deal is now higher up on its list of priorities for the foreseeable future.
Hikma’s Vascepa Launch Strategy ‘Can Cause Market Confusion’
Issues over supply and the use of a skinny label have the potential to take a toll on the market for the fish oil drug icosapent ethyl, one analyst has claimed in the wake of Hikma’s recent generic launch.
Germany Approves Unified Patent Court Ratification Bill
The German Bundestag has adopted the Unified Patent Court’s draft ratification bill with the necessary qualified majority.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: